Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.13) by 58.33 percent. This is a 66.67 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $41.568 million which beat the analyst consensus estimate of $40.175 million by 3.47 percent. This is a 9.08 percent increase over sales of $38.108 million the same period last year.